Pharmacokinetics, Safety and Tolerability of Fevipiprant Delivered Via a Once Daily Chewable Tablet in Children Aged 6 to < 12 Years With Asthma
Clinical trial NCT03650400 · TERMINATED
Trial details
- NCT number
- NCT03650400
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-01
- Primary completion
- 2019-12-16
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.